Source comparison
GHRP-6 Acetate Peptide vs Other Growth Hormone Secretagogues
Below is a comparison of GHRP-6 acetate peptide against other commonly used growth hormone secretagogues in research settings. GHRP-6 Acetate GHSR1a agonist (direct pituitary) ~2.5 hours Pulsatile, peaks at 30 min Moderate increase via hypothalamic GHSR1a Card
This comparison does not assign a generated winner or score.
- Below is a comparison of GHRP-6 acetate peptide against other commonly used growth hormone secretagogues in research settings.
- GHRP-6 Acetate
- GHSR1a agonist (direct pituitary)
- ~2.5 hours
- Pulsatile, peaks at 30 min
- Moderate increase via hypothalamic GHSR1a
- Cardioprotective, anti-inflammatory (GH-independent)
- GHRP-2
- Pulsatile, stronger peak than GHRP-6
- Minimal to none
- Fewer off-target effects; more selective for GH
- Ipamorelin
- GHSR1a agonist (highly selective)
- ~2 hours
- Pulsatile, no prolactin or cortisol elevation
- None
- Most selective; no appetite or stress hormone effects
- Hexarelin
- ~1.5 hours
- Pulsatile, strongest GH release
- Strong increase
- Desensitizes receptors with chronic use
- MK-677 (Ibutamoren)
- GHSR1a agonist (oral bioavailable)
- ~24 hours
- Sustained elevation over 24 hours
- Elevated blood glucose, insulin resistance risk
- CJC-1295
- GHRH analog (hypothalamic pathway)
- ~6–8 days with DAC
- Sustained baseline elevation
- Synergistic with GHRP compounds; requires intact hypothalamic signaling
- GHRP-6 occupies a unique position: it produces reliable pulsatile GH secretion with measurable appetite stimulation, making it useful for studies examining both pathways simultaneously. GHRP-2 and ipamorelin offer cleaner GH-specific effects, but they don't replicate ghrelin's orexigenic (appetite-stimulating) activity. If a research protocol requires both GH release and appetite modulation, GHRP-6 is the most physiologically relevant analog.
- Here's the honest answer: Hexarelin produces the strongest acute GH pulse, but chronic dosing causes receptor desensitization within 4–6 weeks, making it unsuitable for long-term studies. GHRP-6 doesn't desensitize receptors at physiological doses, which is why it remains the standard for repeated-measures GH secretion experiments.